Overview
ten63 therapeutics has secured strategic investment from Chugai Venture Fund and the Gates Foundation, raising its total funding to over $45 million. This funding will aid in the development of its proprietary Beyond platform, which is the first large quantum chemistry model capable of simulating trillions of potential drugs per protein with near laboratory-level accuracy.
Products
Loading...
Recent Deals
Investors: Chugai Venture Fund, Gates Foundation
ten63 therapeutics has secured strategic investment from Chugai Venture Fund and the Gates Foundation, raising its total funding to over $45 million. This funding will aid in the development of its proprietary Beyond platform, which is the first large quantum chemistry model capable of simulating trillions of potential drugs per protein with near laboratory-level accuracy.